Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling
In December 2019, reports of viral pneumonia came out of Wuhan city in Hubei province in China. In early 2020, the causative agent was identified as a novel coronavirus (CoV) sharing some sequence similarity with SARS-CoV that caused the severe acute respiratory syndrome outbreak in 2002. The new vi...
Main Authors: | Zena Wehbe, Safaa Hammoud, Nadia Soudani, Hassan Zaraket, Ahmed El-Yazbi, Ali H. Eid |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00836/full |
Similar Items
-
Two Sulfur Glycoside Compounds Isolated from Lepidium apetalum Willd Protect NRK52e Cells against Hypertonic-Induced Adhesion and Inflammation by Suppressing the MAPK Signaling Pathway and RAAS
by: Peipei Yuan, et al.
Published: (2017-11-01) -
Perirenal Adipose Tissue Inflammation: Novel Insights Linking Metabolic Dysfunction to Renal Diseases
by: Safaa H. Hammoud, et al.
Published: (2021-08-01) -
Specificity models in MAPK cascade signaling
by: Yan Ma, et al.
Published: (2023-07-01) -
Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases
by: Ibrahim AlZaim, et al.
Published: (2020-11-01) -
The RAAS Axis and SARS-CoV-2: From Oral to Systemic Manifestations
by: Minela Aida Maranduca, et al.
Published: (2022-11-01)